Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System: a [18F]-Fallypride- and [18F]-Fluoro-DOPA-PET Study.

NCT03854942 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT03854942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System: a [18F]-Fallypride- and [18F]-Fluoro-DOPA-PET Study.
Lead sponsor
RWTH Aachen University
Phase
Phase 1
Overall status
Terminated
Start date
August 30, 2011
Completion date
December 13, 2017
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol addiction